title: CD40 regulates the processing of NF-kappaB2 p100 to p52.
abstract: The nf-kb2 gene encodes the cytoplasmic NF-kappaB inhibitory protein p100 from which the active p52 NF-kappaB subunit is derived by proteasome-mediated proteolysis. Ligands which stimulate p100 processing to p52 have not been defined. Here, ligation of CD40 on transfected 293 cells is shown to trigger p52 production by stimulating p100 ubiquitylation and subsequent proteasome-mediated proteolysis. CD40-mediated p52 accumulation is dependent on de novo protein synthesis and triggers p52 translocation into the nucleus to generate active NF-kappaB dimers. Endogenous CD40 ligation on primary murine splenic B cells also stimulates p100 processing, which results in the delayed nuclear translocation of p52-RelB dimers. In both 293 cells and primary splenic B cells, the ability of CD40 to trigger p100 processing requires functional NF-kappaB-inducing kinase (NIK). In contrast, NIK activity is not required for CD40 to stimulate the degradation of IkappaBalpha in either cell type. The regulation of p100 processing by CD40 is likely to be important for the transcriptional regulation of CD40 target genes in adaptive immune responses.
authors.affiliation: Divisions of Immune Cell Biology and Yeast Genetics, National Institute for Medical Research, London NW7 1AA, UK.
authors.forename: H J
authors.initials: HJ
authors.lastname: Coope
authors.forename: P G P
authors.initials: PG
authors.lastname: Atkinson
authors.forename: B
authors.initials: B
authors.lastname: Huhse
authors.forename: M
authors.initials: M
authors.lastname: Belich
authors.forename: J
authors.initials: J
authors.lastname: Janzen
authors.forename: M J
authors.initials: MJ
authors.lastname: Holman
authors.forename: G G B
authors.initials: GG
authors.lastname: Klaus
authors.forename: L H
authors.initials: LH
authors.lastname: Johnston
authors.forename: S C
authors.initials: SC
authors.lastname: Ley
mesh_terms: D021581:Active Transport, Cell Nucleus; D000818:Animals; D001402:B-Lymphocytes / Q000276:immunology / Q000378:metabolism; D019013:CD40 Antigens / Q000378:metabolism*; D002460:Cell Line; D003513:Cycloheximide / Q000494:pharmacology; D003546:Cysteine Endopeptidases / Q000378:metabolism; D004268:DNA-Binding Proteins / Q000378:metabolism; D006801:Humans; D020672:I-kappa B Proteins; D008024:Ligands; D051379:Mice; D009097:Multienzyme Complexes / Q000378:metabolism; D000072000:NF-KappaB Inhibitor alpha; D016328:NF-kappa B / Q000235:genetics / Q000378:metabolism*; D052002:NF-kappa B p50 Subunit; D052003:NF-kappa B p52 Subunit; D046988:Proteasome Endopeptidase Complex; D011499:Protein Processing, Post-Translational; D017346:Protein Serine-Threonine Kinases / Q000378:metabolism; D011500:Protein Synthesis Inhibitors / Q000494:pharmacology; D011518:Proto-Oncogene Proteins / Q000378:metabolism; D011994:Recombinant Proteins / Q000235:genetics / Q000378:metabolism; D051841:Transcription Factor RelB; D014157:Transcription Factors / Q000378:metabolism; D014162:Transfection; D025801:Ubiquitin / Q000378:metabolism; D000097782:NF-kappaB-Inducing Kinase
chemical_list: D019013:CD40 Antigens; D003513:Cycloheximide; D003546:Cysteine Endopeptidases; D004268:DNA-Binding Proteins; D020672:I-kappa B Proteins; D008024:Ligands; D009097:Multienzyme Complexes; D000072000:NF-KappaB Inhibitor alpha; D016328:NF-kappa B; D052002:NF-kappa B p50 Subunit; D052003:NF-kappa B p52 Subunit; D046988:Proteasome Endopeptidase Complex; D017346:Protein Serine-Threonine Kinases; D011500:Protein Synthesis Inhibitors; D011518:Proto-Oncogene Proteins; D011994:Recombinant Proteins; D051841:Transcription Factor RelB; D014157:Transcription Factors; D025801:Ubiquitin; D000097782:NF-kappaB-Inducing Kinase; C000606204:NFKBIA protein, human; C000606205:Nfkbia protein, mouse; C497593:RELB protein, human; C497594:Relb protein, mouse